Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 2/2016

01-02-2016 | Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes

Authors: Kevin A. Cook, Andrew A. White

Published in: Current Allergy and Asthma Reports | Issue 2/2016

Login to get access

Abstract

Aspirin allergy in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face. Adverse reactions to aspirin are reported in 1.5 % of patients with coronary artery disease. A history of adverse reaction to aspirin often leads to unnecessary withholding of this medication or use of alternative antiplatelet therapy which may be inferior or more costly. Aspirin therapy has been shown to reduce morbidity and mortality in patients with coronary artery disease. Rapid aspirin challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.
Literature
1.
Amsterdam EA et al. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2354–94.CrossRefPubMed
2.
Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105:997–1001.CrossRefPubMed
3.
De Luca G, Verdoia M, Binda G, et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol. 2013;167(2):561–3.CrossRefPubMed
4.
McMullan KL, Wedner HJ. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol. 2013;36:25–30.CrossRefPubMed
5.
Rossini R, Angiolillo DJ, Musumeci G, et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101:786–9.CrossRefPubMed
6.
Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509–10.CrossRefPubMed
7.
Fajt ML, Petrov AA. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Crit Pathw Cardiol. 2011;10:17–21.CrossRefPubMed
8.
Cortellini G, Testi S, Severino M, et al. Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol. 2012;44(4):160–2.PubMed
9.
Dalmau G, Gaig P, Gazquez V, Merce J. Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance. Rev Esp Cardiol. 2009;62:224–5.CrossRefPubMed
10.
Ortega-Loayza AG, Raza S, Minisi AJ, et al. Aspirin desensitization/challenge in 3 patients with unstable angina. Am J Med Sci. 2010;340:418–20.CrossRefPubMed
11.
Christou A, Kafkas N, Marinakos A, et al. Rapid desensitisation of patients with aspirin allergy who undergo coronary angioplasty. Hell J Cardiol. 2011;52(4):307–10.
12.
Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13e21.CrossRef
13.•
Feng CH, White AA, Stevenson DD. Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol. 2013;110(2):92–5. This article reviews 9,565 patients who were identified in a medical record with CAD and aspirin listed as an “allergy”. The article reports the nature of these reactions and also highlights the underutilization of aspirin challenge/desensitization.CrossRefPubMed
14.
Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug related problems. Drug Saf. 2000;22:415–23.CrossRefPubMed
15.
Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017e3023.CrossRef
16.•
Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–32. A comprehensive review describing the various hypersensitivity syndromes associated with aspirin and NSAIDs. Proposed diagnostic evaluation is also described.CrossRefPubMed
17.
Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676.CrossRefPubMed
18.
Mastalerz L, Setkowicz M, Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep. 2005;5(4):277–83.CrossRefPubMed
19.
Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol. 2015;15(4):314–22.CrossRefPubMed
20.
Katz Y, Goldberg N, Kivity S. Localized periorbital edema induced by aspirin. Allergy. 1993;48:366–9.CrossRefPubMed
21.
Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol. 2010;24:685–91.CrossRefPubMed
22.
Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111:882–8.CrossRefPubMed
23.
Phills J, Perelmutter L. IgE and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol. 1974;29:474–9.CrossRefPubMed
24.
Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62:295–8.PubMed
25.•
Aun MV, Blana M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol. 2014;2:414–20. A review of anaphylaxis caused by medications. In this review NSAIDs are noted to be the most frequent cause of anaphylaxis in patients presenting to the emergency department with a drug reaction. The article also reports an underutilization of epinephrine in patients presenting with anaphylaxis.CrossRef
26.
Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67(3):206–13.CrossRefPubMed
27.
Aseros R. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2005;35:713–6.CrossRef
28.
The CURRENT–OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363:10.CrossRef
29.
Anderson JL, Adams CD, Antman EM. 2011 ACCF/AHA focused update on the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation. 2011;123:2022–60.CrossRefPubMed
30.
Kern M. Conversations in cardiology: what to do if your patient can’t take aspirin after stenting. Cath Lab Digest. 2014;22:10.
31.
Metadata
Title
Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes
Authors
Kevin A. Cook
Andrew A. White
Publication date
01-02-2016
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 2/2016
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-015-0593-2

Other articles of this Issue 2/2016

Current Allergy and Asthma Reports 2/2016 Go to the issue

Allergens (RK Bush and JA Woodfolk, Section Editors)

T Cell Epitope Peptide Therapy for Allergic Diseases

Rhinosinusitis (J Mullol, Section Editor)

Risk Factors and Comorbidities in Chronic Rhinosinusitis

Immune Deficiency and Dysregulation (DP Houston and C Kuo, Section Editors)

Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue

Rhinitis (JJ Oppenheimer and J Corren, Section Editors)

Adherence to Sublingual Immunotherapy

Allergens (RK Bush and JA Woodfolk, Section Editors)

The Immunologic Mechanisms of Eosinophilic Esophagitis

Rhinitis (JJ Oppenheimer and J Corren, Section Editors)

Understanding Biofilms in Chronic Sinusitis